Cost-effectiveness of Point-of-care Biomarker Assessment for Suspected Myocardial Infarction: The Randomized Assessment of Treatment Using Panel Assay of Cardiac Markers (RATPAC) Trial-Reference-Cited by-同舟云学术

Cost-effectiveness of Point-of-care Biomarker Assessment for Suspected Myocardial Infarction: The Randomized Assessment of Treatment Using Panel Assay of Cardiac Markers (RATPAC) Trial

Published:2011-05 Issue:5 Volume:18 Page:488-495
ISSN:1069-6563
Container-title:Academic Emergency Medicine
language:en
Short-container-title:

Author:

Fitzgerald Patrick,Goodacre Steve W.,Cross Elizabeth,Dixon Simon

Publisher

Wiley

Subject

Emergency Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1553-2712.2011.01068.x/fullpdf

Reference13 articles.

1. The health care burden of acute chest pain;Goodacre;Heart.,2005

2. Point of care testing;Price;BMJ.,2001

3. The RATPAC Trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers): a randomised controlled trial of point-of-care cardiac markers in the emergency department;Goodacre;Heart.,2011

4. National Institute for Health and Clinical Excellence Guidance for the Management of Acute Chest Pain http://guidance.nice.org.uk/CG95

5. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force Report;Ramsey;Value Health.,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome;Heart;2023-12-01

2. Quality of health economic evaluations in emergency medicine journals: a systematic review;Canadian Journal of Emergency Medicine;2023-06-30

3. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation;Health Technology Assessment;2021-05

4. Health Economic Evidence of Point-of-Care Testing: A Systematic Review;PharmacoEconomics - Open;2021-01-06

5. Troponin Levels at Presentation Before Coronary Angiogram and Their Association With Cost, Mortality, and Readmission;Cureus;2020-12-13